Related Experiment Videos
[Pulmonary infection in immunocompromised hosts]
Tsuneo Suzuki1, Takeo Kawashiro
1National Hospital Organization Higashi Saitama Hospital, Saitama, Japan.
Nihon Geka Gakkai Zasshi
|January 18, 2005
Summary
Surgical lung resection is necessary for specific pulmonary infections, including those in immunocompromised patients, drug-resistant cases, and infections with no effective treatments like Aspergillus and multidrug-resistant tuberculosis.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Surgical Oncology
Background:
- Most pulmonary infections are treatable with antimicrobial agents.
- Certain complex infections necessitate surgical intervention.
- Advancements in cancer therapy increase immunocompromised patient populations.
Purpose of the Study:
- To outline the indications for surgical lung resection in pulmonary infections.
- To discuss specific challenging microbial pathogens requiring surgical management.
- To highlight the physician's perspective on these complex cases.
Main Methods:
- Review of clinical scenarios requiring surgical lung resection for pulmonary infections.
- Discussion of cases involving immunocompromised patients.
- Analysis of infections with antimicrobial resistance or lack of effective drugs.
Main Results:
- Surgical lung resection is indicated for pulmonary infections in immunocompromised patients.
- Infections caused by drug-resistant microorganisms, such as multidrug-resistant tuberculosis and Aspergillus species, often require surgery.
- Massive hemoptysis from Aspergillus infections in prior tuberculosis sites necessitates resection.
Conclusions:
- Surgical lung resection is a critical treatment modality for select pulmonary infections.
- Indications include immunocompromised status, antimicrobial resistance, and untreatable pathogens.
- Prompt surgical intervention is vital for managing severe complications like hemoptysis.